The effects of chrysin, a Passiflora incarnata extract, on natural killer cell activity in male Sprague-Dawley rats undergoing abdominal surgery

AANA Journal

Volumn 76, Issue 2, 2008, Pages 113-117

  Beaumont, Denise M ^a   Mark Jr , Terrence M ^b   Hills, Reginald ^c   Dixon, Patricia ^d   Veit, Bruce ^e   Garrett, Normalynn ^f  

^a Carl R Darnell Army Medical Center   (United States)

^b WOMACK ARMY MEDICAL CENTER   (United States)

^c Reynolds Army Community Hospital   (United States)

^d WILFORD HALL MEDICAL CENTER   (United States)

^e WILLIAM BEAUMONT ARMY MEDICAL CENTER   (United States)

^f US Army Graduate Program in Anesthesia Nursing   (United States)

Author keywords

Anxiety; Chrysin; Natural killer cells; Passion flower

Indexed keywords

CHRYSIN; DIMETHYL SULFOXIDE; ISOFLURANE; PASSIFLORA INCARNATA EXTRACT; SODIUM CHLORIDE;

ABDOMINAL SURGERY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFECT; FLOWER; MALE; MEDICINAL PLANT; METASTASIS INHIBITION; NATURAL KILLER CELL; NONHUMAN; PASSIFLORA INCARNATA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RAT;

ADMINISTRATION, INHALATION; ANALYSIS OF VARIANCE; ANESTHETICS, INHALATION; ANIMALS; DIMETHYL SULFOXIDE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FLAVONOIDS; GABA AGONISTS; IMMUNE TOLERANCE; ISOFLURANE; KILLER CELLS, NATURAL; LAPAROTOMY; LYMPHOCYTE COUNT; MALE; PASSIFLORA; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SOLVENTS; TIME FACTORS;

EID: 42049086165     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. American Cancer Society Homepage. http://www.cancer.org/docroot/home/ index.asp. Accessed October 1, 2006.
2. Pollock RE, Babcock GF, Romsdahl MM, Nishioka K. Surgical stress-mediated suppression of murine natural killer cell cytotoxicity. Cancer Res. 1984;44(9):3888-3389.
3. Tseng RJ, Padgett DA, Dhabhar FS, Engler H, Sheridan JF. Stress-induced modulation of NK activity during influenza viral infection: role of glucocorticoids and opioids. Brain Behav Immun. 2005;19(2):153-164.
4. Lutgendorf SK, Sood AK, Anderson B, et al. Social support, psychological distress, and natural killer cell activity in ovarian cancer. J Clin Oncol. 2005;23(28):7105-7113.
5. Kronfol Z, Nair M, Zhang Q, Hill EE, Brown MB. Circadian immune measures in healthy volunteers: relationship to hypothalamic-pituitary-adrenal axis hormones and sympathetic neurotransmitters. Psychosom Med. 1997;59(1):42-50.
6. Naito A, Laidlaw TM, Henderson DC, Farahani L, Dwivedi P, Gruzelier JH. The impact of self-hypnosis and Johrei on lymphocyte subpopulations at exam time: a controlled study. Brain Res Bull. 2003;62(3):241-253.
7. Colucci F, Caligiuri MA, DiSanto JP. What does it take to make a natural killer? Immunology. 2003;3(5)413-425.
8. Locke SE, Kraus L, Leserman J, Hurst MW, Heisel JS, Williams RM. Life change stress, psychiatric symptoms, and natural killer cell activity. Psychosom Med. 1984;46(5):441-453.
9. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003;97(5):1331-1339.
10. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999;80(6):880-888.
11. Zhou FL, Zhang WG, Wei YC, et al. Impact of comorbid anxiety and depression on quality of life and cellular immunity changes in patients with digestive tract cancers. World J Gastroenterol. 2005;11(15):2313-2318.
12. Koga C, Itoh K, Aoki M, et al. Anxiety and pain suppress the natural killer cell activity in oral surgery patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(6):654-658.
13. Page GG, Ben-Eliyahu S, Liebeskind JC. The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav Immun. 1994;8(3):241-250.
14. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol. 2003;10(8):972-992.
15. Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26(5):363-367.
16. Salgueiro JB, Ardenghi P, Dias M, Ferreira MB, Izquierdo I, Medina JH. Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol Biochem Behav. 1997;58(4):887-891.
17. Wolfman C, Viola H, Paladini A, Dajas F, Medina JH. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol Biochem Behav. 1994;47(1):1-4.
18. Tobin PJ, Beale P, Noney L, Liddell S, Rivory LP, Clarke S. A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irtnotecan (CPT-11) to treat metastatic colorectal cancer. Cancer Chemother Pharmacol. 2006;57(3):309-316.
19. Dhawan K, Kumar K, Sharma A. Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia. 2001;72(8):922-926.
20. Zanoli P, Avallone R, Baraldi M. Behavioral characterization of the flavonoids apigenin and chrysin. Fitoterapia. 2000;71(suppl 1):S117-S123.
21. Dhawan K, Kumar S, Sharma A. Suppression of alcohol-cessation-oriented hyper-anxiety by the benzoflavone moiety of Passiflora incarnata linneaus in mice. J Ethnopharmacol. 2002;81(2):239-244.
22. Page GG, Ben-Eliyahu S, Yirmiya R, Liebeskind JC. Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain. 1993;54(1):21-28.
23. Brunner KT, Mauel J, Cerottini JC, Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro: inhibition by isoantibody and by drugs. Immunology. 1968;14(2):181-196.
24. Bryant J, Day R, Whiteside TL, Herberman RB. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J Immunol Methods. 1992;146(1):91-103.
25. Benschop RJ, Jacobs R, Sommer B, et al. Modulation of the immunologic response to acute stress in humans by beta-blockade or benzodiazepines. FASEB J. 1996;10(4):517-524.
26. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988:274.
27. Freire-Garabal M, Nunez MJ, Balboa JL, Gonzalez-Bahillo J, Belmonte A. Effects of midazolam on the activity of phagocytosis in mice submitted to surgical stress. Pharmacol Biochem Behav. 1993;46(3):605-608.
28. Freire-Garabal M, Nunez MJ, Balboa JL, et al. Effects of alprazolam on cellular immune response to surgical stress in mice. Cancer Lett. 1993;73(2-3):155-160.
29. Fride E, Meng R, Skolnick P, Arora PK. Immunoenhancing effects of alprazolam, a benzodiazepine receptor agonist. Ann N Y Acad Sci. April 15 1992;650:132-139.
30. Fride E, Skolnick P, Arora PK. Immunoenhancing effects of alprazolam in mice. Life Sci. 1990;47(26):2409-2420.
31. Irwin M, Hauger RL, Britton K. Benzodiazepines antagonize central corticotropin releasing hormone-induced suppression of natural killer cell activity. Brain Res. 1993;631(1):114-118.
32. Gao Y, Tang W, Dai X, et al. Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer. J Med Food. 2005;8(2):159-168.
33. Kamiyama H, Takano S, Ishikawa E, Tsuboi K, Matsumura A. Antiangiogenic and immunomodulatory effect of the herbal medicine "Juzen-taiho-to" on malignant glioma. Biol Pharm Bull. 2005;28(11):2111-2116.
34. Mediratta PK, Sharma KK. Differential effects of benzodiazepines on immune responses in non-stressed and stressed animals. Indian J Med Sci. 2002;56(1):9-15.
35. Mediratta PK, Bhiatia S, Tewary V, Katyal P, Mahjan P, Sharma KK. Attenuation of the effect of progesterone and 4-cilordiazepam on stress-induced immune responses by bicuculline. Indian J Physiol Pharmacol. 2003;47(3):288-296.
36. Galiegue S, Tinel N, Casellas P. The peripheral benzodiazepine receptor: a promising therapeutic drug target. Curr Med Chem. 2003;10(16):1563- 1572.
37. Sutter AP, Maaser K, Grabowski P, et al. Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1. J Hepatol. 2004;41(5):799-807.
38. Furre IE, Shahzidi S, Luksiene Z, et al. Targeting PBR by hexaminole-vulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res. 2005;65(23):11051-11060.
39. Decaudin D, Castedo M, Nemati F, et al. Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Cancer Res. 2002;62(5):1388-1393.
40. Harris GK, Qian Y, Leonard SS, Sbarra DC, Shi X. Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. J Nutr. 2006;136(6):1517-1521.
41. Cardenas M, Marder M, Blank VC, Roguin LP. Antitumor activity of some natural flavonoids and synthetic derivatives on various human and murine cancer cell lines. Bioorg Med Chem. 2006;14(9):2966-2971.
42. Weng MS, Ho YS, Lin JK. Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1 expression: involvement of p38 mitogen-activated protein kinase. Biochem Pharmacol. 2005;69(12):1815- 1827.
43. Woo KJ, Jeong YJ, Park JW, Kwon TK. Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells. Biochem Biophys Res Commun. 2004;325(4):1215-1222.
44. Ohwada S, Ogawa T, Makita F, et al. Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: analysis of immunological parameters. Oncol Rep. 2006;15(4):861-868.
45. Wu JD, Higgins LM, Steinle A, Cosman D, Haugk K, Plymate SR. Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J Clin Invest. 2004;114(4):560-568.
46. Arnould L, Gelly M, Penault-Llorca F, et al. Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? Br J Cancer 2006;94(2):259-267.
47. Bobek V, Boubelik M, Fiserova A, et al. Anticoagulant drugs increase natural killer cell activity in lung cancer. Lung Cancer. 2005;47(2):215-223.